The Comprehensive Center for Brain Health (CCBH) at the University of Miami Miller School of Medicine is a research center and clinical unit in the Department of Neurology and led by Founding Director and Principal Investigator Dr. James E. Galvin, MD, MPH. CCBH prides itself on its dedication to the foundational pillars of Innovative Research, Clinical Care, Education and Training, and Community Outreach and Engagement.
CCBH is located at 7700 W. Camino Real, Suite 200, Boca Raton, FL 33433
Take a look inside CCBH and see how we're leading the way to better brain health.
Watch the video of American Academy of Neurology's visit to CCBH in Boca Raton. (video 5:15 mins)
Read our Newsletter
Our CCBH Newsletter provides photos and snippets of our many efforts, contributions, impacts, and collaborations. Be sure to keep up with us and join our events.
Participate in Research
We have observational and clinical studies. Research participants are vital to improve our understanding of healthy brain aging, risk factors, and predictors of memory disorders.
CCBH
Services
Our expert CCBH clinicians provide personalized patient care services specializing in cognivtive neurological disease prevention and management, psychotherapy, and nutrition.
Support our Research
Your philanthropic investment can help us expand the breadth and depth of our efforts in research, clinical care, and education and training.
Go to DONATE
Helpful Data Tools
CCBH Founding Director and Principle Investigator, Dr. James E. Galvin, MD has developed multiple assessment tools to share with clinicians and researchers.
Go to TOOLS
Current Grants
A comprehensive, customized focus on prevention and health, rather than disease, is at the heart of our work at the CCBH. We’re on a mission to better understand how the aging brain works, and design treatments and prevention plans that will result in longer, better lives. We seek to prevent or delay the onset of these devastating diseases by 50 percent, curbing the suffering of hundreds of thousands of Americans. Here is an inventory of our current grant portfolio
Multicultural Community Dementia Screening
To conduct a population-based dementia screening, validate findings in a longitudinal study of ADRD biomarkers, and establish the potential benefits and harms of dementia screening in a multicultural sample
Natives Engaged in Alzheimer’s Research (NE…
To engage, enroll and study American Indians, Alaskan Natives, and Native Hawaiians and Pacific Islanders in novel Alzheimer detection and treatment interventions and encourage biomarker and autopsy program participation
A Randomized, Double-Blind, Placebo-Controlle…
To conduct a Phase 2 clinical trial of CT1812, a novel disease-modifying compound, in patients with mild to moderate dementia with Lewy bodies (DLB)
Multicultural Community Dementia Screening
To conduct a population-based dementia screening, validate findings in a longitudinal study of ADRD biomarkers, and establish the potential benefits and harms of dementia screening in a multicultural sample
To conduct a population-based dementia screening, validate findings in a longitudinal study of ADRD biomarkers, and establish the potential benefits …
Natives Engaged in Alzheimer’s Research (NE…
To engage, enroll and study American Indians, Alaskan Natives, and Native Hawaiians and Pacific Islanders in novel Alzheimer detection and treatment interventions and encourage biomarker and autopsy program participation
To engage, enroll and study American Indians, Alaskan Natives, and Native Hawaiians and Pacific Islanders in novel Alzheimer detection and …